Rozencwaig Richard MD - Miami, Florida 33180

Rozencwaig Richard MD is categorized under Internal Medicine Doctors in Miami, FL .

Business Name: Rozencwaig Richard MD
Contact Person: Richard Rozencwaig
Address: 21000 Ne 28th Avenue # 104, Miami, Florida 33180
Phone Number: (305) 937-1999
Website Address: orthopedicare.com
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Dr Stanley S Zimmelman Do - Miami, FL 33180
Posner Ira MD - Miami, FL 33180
Garcia Rolando MD - Miami, FL 33180
The Medical Center Of Winston Towers Inc - Miami, FL 33180
Braver Beth R MD - Miami, FL 33180
Lerer Solomon L MD - Miami, FL 33180
Nathaniel Keller - Miami, FL 33180
Skin And Cancer Associates - Miami, FL 33180
Gilinsky Michael MD - Miami, FL 33180
Epstein Bryce E MD - Miami, FL 33180
Ackermann Alan DO - Miami, FL 33180
Antonio Fernandez Md - Miami, FL 33180
Enrique M Ciklik Md - Miami, FL 33180
Bernstein & Mesa LLC - Miami, FL 33180
Cardiomedical Associates - Miami, FL 33180
Edward Frankoski Do - Miami, FL 33180
Gorin Steven DO - Miami, FL 33180

The company Rozencwaig Richard MD provides B2C services in the form of Internal Medicine Doctors from its single location in Florida. 1 to 4 employees work for Rozencwaig Richard MD, and the business now earns $500.000 to $999.999 per annum.

Rozencwaig Richard MD was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Rozencwaig Richard MD, please call Richard Rozencwaig with the phone number (305) 937-1999 or visit its single location at 21000 Ne 28th Avenue # 104 in Miami, Florida 33180.

The location of the single location can also be found using the coordinates 25.96989,-80.14588. Read more details about this business on the webpage orthopedicare.com or follow the company’s social media accounts, on Twitter and on Facebook.